ClinicalTrials.gov is the most comprehensive clinical trial database in the world — over 500,000 studies, updated daily, completely free to use. It's also genuinely confusing for most people. Dense medical language, cryptic status labels, and a search interface that rewards specialists over patients means most people either give up or miss the trials most relevant to them.
This guide fixes that. It explains exactly how to search, what the results mean, and which filters actually matter.
About this article: Educational and informational only. ClinicalTrials.gov is a public registry maintained by the U.S. National Library of Medicine. Finding a trial on this site does not mean you are eligible to enroll. Always confirm trial status and eligibility with the research team and discuss options with your physician.
In This Article
- 1.What ClinicalTrials.gov Actually Is
- 2.Why Most Patients Struggle With It
- 3.Step 1: Use the Right Search Terms
- 4.Step 2: Set the Status Filter to "Recruiting"
- 5.Step 3: Use Location Search Correctly
- 6.Step 4: Reading a Trial Record
- 7.Step 5: Decoding Eligibility Criteria
- 8.Step 6: Making Contact
- 9.When an AI Tool Can Help
- 10.Frequently Asked Questions
What ClinicalTrials.gov Actually Is
ClinicalTrials.gov is a registry and results database operated by the U.S. National Library of Medicine (NLM), part of the National Institutes of Health. Since 2000, federal law has required most clinical trials conducted in the United States — and many international trials — to register here before enrolling participants.
This means every entry on ClinicalTrials.gov is a study that actually exists. Sponsors are legally required to keep their listings current, including updating the status when a trial closes to enrollment. The database is the closest thing to a ground truth for what is actually recruiting right now.
What it is not: a matching service, a screening tool, or a place that will tell you whether you personally qualify for any trial. Those answers require talking to the research team.
Why Most Patients Struggle With It
Three problems trip up most users:
- Too many results, wrong conditions. Searching “cancer” returns tens of thousands of studies. Most are irrelevant to any specific patient. The default search doesn't filter by recruiting status, so most results are for closed or completed trials.
- Eligibility criteria are written for clinicians. Terms like “ECOG performance status ≤ 2,” “anti-TNF naive,” or “adequate hepatic function per institutional criteria” are incomprehensible without a medical background.
- Status labels are misleading. A trial listed as “Active, not recruiting” is not the same as “Recruiting.” Many patients contact trials that closed enrollment months ago.
All three problems are solvable. Here's how.
Step 1: Use the Right Search Terms
The condition search on ClinicalTrials.gov matches against study titles, official condition names, and free-text fields. A few rules that consistently improve results:
- Use the medical name when possible. “Plaque psoriasis” returns more targeted results than “psoriasis” alone. “Type 2 diabetes mellitus” is more precise than “diabetes.”
- Try both brand and generic names. Searching for a specific drug by name (e.g., “adalimumab” instead of “Humira”) often returns different results.
- Add a subtype if you have one. “Triple-negative breast cancer” is much more specific than “breast cancer” and will return trials actually relevant to that subtype.
- If too few results, broaden. Try the parent condition. “ Inflammatory bowel disease” will catch both Crohn's and ulcerative colitis trials.
Quick tip
If your condition has an ICD-10 code (your doctor can tell you), search that code directly. ICD-10 codes like “C50” (breast cancer) or “M32” (SLE) retrieve studies tagged to that specific diagnostic category.
Step 2: Set the Status Filter to “Recruiting”
This is the single most important filter on the site — and the one most people miss.
By default, ClinicalTrials.gov shows results across all statuses: completed trials, terminated studies, trials that are active but no longer enrolling, and studies still in planning. The majority of results for any common condition will not be enrolling new participants.
On the search results page, look for the Status filter in the left sidebar and select “Recruiting” only. The results list will shrink dramatically — and the trials that remain are the ones actually open to you.
Status labels decoded
Step 3: Use Location Search Correctly
The location filter narrows results to trials with sites near you — but it has quirks.
- Search by state, not just city. Many trials have multiple sites across a state. A city search might miss a site one county over.
- Distance filter defaults to 50 miles. Increase it if you're willing to travel more. For rare diseases, national and international sites are often the only options.
- Some trials have no location listed because they're decentralized (remote participation by telemedicine and home nursing). Don't filter these out — they may not require travel at all.
- New sites are added as trials expand. A trial without a local site today may add one in six months. Worth revisiting if the trial looks otherwise relevant.
Step 4: Reading a Trial Record
Every trial page has the same structure. Here's what to look at and in what order:
Brief Title + Official Title
The brief title is plain language. The official title is usually the protocol name. If the official title includes a drug name or mechanism (e.g., "anti-IL-17"), that tells you the class of therapy being tested.
Brief Summary
A 2–4 paragraph plain-language description of what's being tested and why. This should give you a clear sense of whether the trial is relevant to your situation.
Overall Status
"Recruiting" means open. Anything else means you're looking at a closed or paused trial.
Eligibility Criteria
The most important section — and the hardest to read. See Step 5 below.
Locations
A list of all trial sites globally. Click "Show all" — it defaults to showing only a few. Each site includes a contact name and email or phone number.
Contacts
The central contact (typically at the sponsor) and/or site-specific contacts. This is who you email or call to ask about screening.
Step 5: Decoding Eligibility Criteria
Eligibility criteria split into two lists: inclusion criteria (you must meet all of these) and exclusion criteria (any one of these disqualifies you). A few common terms decoded:
| Term | What it means |
|---|---|
| ECOG ≤ 2 | A performance scale. 0 = fully active; 1 = restricted but ambulatory; 2 = capable of self-care, up 50%+ of day. Most patients with an active life are ECOG 0–1. |
| Biologic-naive | You have never been treated with a biologic medication for this condition. |
| Prior anti-TNF failure | You've tried a TNF-blocking drug (e.g., adalimumab, etanercept) and it didn't work or you couldn't tolerate it. |
| Washout period | A required gap between stopping your current medication and starting the trial. Commonly 4–12 weeks. |
| Adequate hepatic/renal function | Your liver or kidney lab values must fall within defined normal ranges. Routinely tested during screening. |
| CDAI / PASI / DAS28 | Disease activity scores for Crohn's, psoriasis, and rheumatoid arthritis respectively. Your doctor can calculate these. |
| No prior malignancy within 5 years | If you've had cancer recently, this exclusion may apply. Skin cancer (excluding melanoma) and cervical CIS are often excluded from this restriction. |
Don't self-disqualify based on eligibility criteria you don't fully understand. If a criterion is unclear, write it down and ask the research coordinator. Terms that look like hard exclusions sometimes have nuance in practice.
Step 6: Making Contact
Found a potentially relevant trial? Here's how to proceed:
- Find the contact information. Look in the Contacts section or the Locations section for the site nearest you. Most listings include an email or phone number for the research coordinator.
- Send a brief, clear inquiry. You don't need a lot of detail. Something like: “I have [condition], [brief relevant history]. I'm interested in NCT[number]. Could you tell me whether I might qualify for a screening visit?”
- Expect a few days' turnaround. Research coordinators manage multiple studies. A follow-up after 5–7 business days is appropriate.
- Discuss with your physician before the screening visit. Your doctor may have relevant history or concerns — and the trial team will likely ask for medical records.
Rather skip the manual search?
Tidera searches ClinicalTrials.gov in real time, filters to recruiting trials only, and explains eligibility in plain English — matched to your condition, age, location, and treatment history.
Try Tidera Free →When an AI Tool Can Help
ClinicalTrials.gov is designed for completeness, not usability. A growing number of tools — including Tidera Health — use the same underlying data but layer in AI to translate eligibility criteria into plain English, score trial fit against a patient profile, and surface the questions most worth asking.
These tools don't replace ClinicalTrials.gov — they make it accessible. Any promising result you find through an AI tool should be verified directly on ClinicalTrials.gov before you contact the research team.
Frequently Asked Questions
Is ClinicalTrials.gov only for U.S. trials?
No. While it's a U.S. government database, federal law requires registration of trials with U.S. sites regardless of where else they run. Many multinational trials register here even if the lead site is in Europe or Asia. You can filter by country under the Location section.
How current is the data?
Sponsors are required to update trial status within 30 days of a change. Most major sponsors update more frequently. However, some smaller studies — particularly academic trials — do lag. Always confirm recruiting status directly with the site before scheduling a screening visit.
Why does the same trial appear multiple times?
It usually doesn't — but trials with multiple sub-studies, protocol amendments, or phase extensions may have separate NCT numbers. These are distinct studies. Read each record carefully.
What is an NCT number?
Every trial registered on ClinicalTrials.gov receives a unique identifier starting with “NCT” followed by eight digits (e.g., NCT05123456). This number is the canonical reference for the trial. When contacting a research team or discussing a trial with your doctor, always reference the NCT number.
Can I use ClinicalTrials.gov to find out if a trial is legitimate?
Yes. A trial registered on ClinicalTrials.gov has passed through a registration process and has a verifiable sponsor and IRB. If someone contacts you about a trial that doesn't appear on ClinicalTrials.gov, treat it with extreme caution.